Home > Signal Pathway > Stem Cells & Wnt > Casein Kinase(CK1/CK2)

Casein Kinase(CK1/CK2)


Casein kinase activity was found to be present in most cell types and to be associated with multiple enzymes.  The Casein kinase 1 family of protein kinases are serine/threonine-selective enzymes that function as regulators of signal transduction pathways in most eukaryotic cell types. CK1 isoforms are involved in Wnt signaling, circadian rhythms, nucleo-cytoplasmic shuttling of transcription factors, DNA repair, and DNA transcription. The type 1 casein kinase family of related gene products are now given designations such as "casein kinase 1 alpha" and "casein kinase 1 epsilon". The Casein kinase 2 is a serine/threonine-selective protein kinase that is a tetramer of two alpha subunits and two beta subunits. The alpha subunits have the catalytic kinase domain. Casein kinase 2 has been implicated in cell cycle control, DNA repair, regulation of the circadian rhythm and other cellular processes. Casein kinase 2 activity has been reported to be activated following Wnt signaling pathway activation. 
  • CKI 7 dihydrochloride EI0818

    CKI 7 dihydrochloride是CK1 抑制剂。

    More
  • (R)-DRF053 dihydrochloride EI0127

    (R)-DRF053 dihydrochloride是Dual CK1/cdk 抑制剂。

    More
  • TMCB EI2788

    TMCB是双效的激酶抑制剂, 抑制CK2,ERK8。

    More
  • PF 670462 EI2136

    PF 670462是活性的,选择性 CK1ε and CK1δ 抑制剂。

    More
  • CX-4945 EY0441

    CX-4945 (Silmitasertib), a selective, potent and orally bioavailable inhibitor of potent casein kinase II (CK2), is the first small molecule inhibitor of CK2 to progress to human clinical trials. CX-4945 (Silmitasertib)是高活性ATP竞争性CK2抑制剂,对重组型人CK2α的Ki和IC50分别为0.38和1 nM。

    More
  • CKI 7 dihydrochloride EI0818

    CKI 7 dihydrochloride是CK1 抑制剂。

    More
  • (R)-DRF053 dihydrochloride EI0127

    (R)-DRF053 dihydrochloride是Dual CK1/cdk 抑制剂。

    More
  • TMCB EI2788

    TMCB是双效的激酶抑制剂, 抑制CK2,ERK8。

    More
  • PF 670462 EI2136

    PF 670462是活性的,选择性 CK1ε and CK1δ 抑制剂。

    More
  • CX-4945 EY0441

    CX-4945 (Silmitasertib), a selective, potent and orally bioavailable inhibitor of potent casein kinase II (CK2), is the first small molecule inhibitor of CK2 to progress to human clinical trials. CX-4945 (Silmitasertib)是高活性ATP竞争性CK2抑制剂,对重组型人CK2α的Ki和IC50分别为0.38和1 nM。

    More
  • Current page1, Total Pages2, Total Record7 First Prev 12 Next Last Goto